跳至主要内容
临床试验/KCT0000623
KCT0000623招募中未知

A prospective, single-center, randomized study to evaluate the effect of sarpogrelate, a selective serotonin receptor antagonist, and high dose statin on the reduction of coronary spasm in the patients with variant angina

Samsung Medical Center0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 70(Year)(—)
性别
All

入选标准

  • 1) Age 20 ~ 70 years old
  • 2) Clinical history of chest pain compatible with variant angina; morning
  • chest pain aggravated by cold exposure.
  • 3) Angiographically proven coronary spasm; TIMI flow < 3 by spontaneous
  • coronary spasm or intracoronary ergonovine spasm provocation test.

排除标准

  • 1) Cardiac arrest by coronary spasm
  • 2) Left main coronary spasm
  • 3) Significant fixed coronary artery stenosis; Diameter stenosis > 70% in the
  • major epicardial artery by coronary angiography
  • 4) LV ejection fraction < 30%
  • 5) Coagulation disorders or bleeding tendency
  • (Platelet count < 50k, PT INR > 2.0)
  • 6) Significant liver disease (AST or ALT > 100 U/ml)
  • 7) Renal failure (S-Cr > 2.0 mg/dl)
  • 8) hypersensitivity for statin
  • 9) Pregnancy

研究者

相似试验